Search

Displaying results 8161 - 8170 of 10000 in total
  1. Drug

    GDC-0917

    go.drugbank.com/drugs/DB12336
    Investigational

    CUDC-427 has been used in trials studying the treatment of LYMPHOMA and Solid Cancers.

  2. Drug

    Zamicastat

    go.drugbank.com/drugs/DB12389
    Investigational

    Zamicastat has been used in trials studying the treatment of Hypertension and Chronic Heart Failure.

  3. Drug

    Decernotinib

    go.drugbank.com/drugs/DB12566
    Investigational

    Decernotinib has been used in trials studying the treatment of Drug Interactions and Rheumatoid Arthritis.

  4. Drug

    Piperine

    go.drugbank.com/drugs/DB12582
    Investigational

    Bioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders.

  5. Drug

    Salirasib

    go.drugbank.com/drugs/DB12681
    Investigational

    Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung.

  6. Drug

    UK-432097

    go.drugbank.com/drugs/DB12691
    Investigational

    UK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  7. Drug

    Duvoglustat

    go.drugbank.com/drugs/DB03206
    Investigational

    An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.

  8. Drug

    SRD-001

    go.drugbank.com/drugs/DB25902
    Investigational

    SRD-001 is under investigation in clinical trial NCT06224660 (Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy).

  9. Drug

    Drostanolone

    go.drugbank.com/drugs/DB00858
    ExperimentalIllicit

    Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone therapy.

  10. Drug

    LGD-6972

    go.drugbank.com/drugs/DB14779
    Investigational

    LGD-6972 is under investigation in clinical trial NCT01919684 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes